— Know what they know.
Not Investment Advice

RPRX NASDAQ

Royalty Pharma plc
1W: -1.8% 1M: -9.4% 3M: +0.4% YTD: +47.9% 1Y: +58.2% 3Y: +127.9% 5Y: +70.8%
$57.16
-0.47 (-0.82%)
 
Weekly Expected Move ±3.2%
$53 $55 $57 $59 $61
NASDAQ · Healthcare · Medical - Pharmaceuticals · Tech Score Sell · Power 40 · $25.3B mcap · 415M float · 0.803% daily turnover · Short 44% of daily vol

📊 Key Metrics

TTM
$3B
Revenue
+10.0% YoY
$815M
Net Income
-20.1% YoY
$3B
Free Cash Flow
+20.5% YoY
60.2%
Gross Margin
19.7%
Op. Margin
2.7%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE12.4%
ROA4.3%
ROIC10.6%

Valuation

P/E23.7
P/B3.7
EV/EBITDA22.9

Leverage

Debt/Equity1.31
Current Ratio1.29
Interest Cov.4.7x

Quality Scores

Piotroski F6/9
Altman Z2.46
Beneish M21.99

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms